NCT00001944View on ClinicalTrials.gov

Vinorelbine and XR9576 to Treat Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 1999

Study Completion Date

June 30, 2001

Conditions
Breast CancerCancerLung CancerOvarian Cancer
Interventions
DRUG

Vinorelbine

DRUG

XR9576

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00001944 - Vinorelbine and XR9576 to Treat Cancer | Biotech Hunter | Biotech Hunter